FIM
WST icon

Freedom Investment Management’s West Pharmaceutical WST Stock Holding History

Freedom Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-629
Closed -$295K – 962
2021
Q4 		$295K Buy
+629
New +$271K 0.02% 679
2021
Q1 		– Sell
-740
Closed -$210K – 913
2020
Q4 		$210K Buy
+740
New +$208K 0.02% 565
2020
Q2 		– Sell
-1,631
Closed -$259K – 696
2020
Q1 		$259K Sell
1,631
-7
-0.4% -$1.08K 0.02% 553
2019
Q4 		$246K Sell
1,638
-242
-13% -$35.2K 0.02% 568
2019
Q3 		$267K Buy
+1,880
New +$259K 0.02% 555
2018
Q3 		– Sell
-4,488
Closed -$446K – 978
2018
Q2 		$446K Buy
+4,488
New +$413K 0.03% 600
2018
Q1 		– Sell
-3,661
Closed -$361K – 1224
2017
Q4 		$361K Sell
3,661
-326
-8% -$32K 0.02% 799
2017
Q3 		$384K Buy
3,987
+667
+20% +$60.4K 0.02% 716
2017
Q2 		$314K Buy
+3,320
New +$305K 0.02% 769

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Freedom Investment Management's WST Position: Q1 2022 in Review

Freedom Investment Management sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 629 shares — an estimated $295K sold.

Freedom Investment Management first reported a position in WST in Q2 2017 and held it in 9 quarters. The position peaked at $446K in Q2 2018. 716 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • Freedom Investment Management reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 629 West Pharmaceutical shares in Q1 2022, an estimated $295K.
  • Freedom Investment Management first reported a position in West Pharmaceutical in Q2 2017 and held it in 9 quarters.
  • Freedom Investment Management's West Pharmaceutical position peaked at $446K in Q2 2018.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.